ID
18875
Description
Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors WTZ-GIST-09-01 (EudraCT number: 2009-011417-24; German Clinical Trials Register: DRKS00000657) was approved by the institutional ethics committees of the two participating centers and the German Federal Regulatory Drug Agency (BfArM; 4035954).
Keywords
Versions (2)
- 11/20/16 11/20/16 -
- 11/23/16 11/23/16 -
Uploaded on
November 23, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC-ND 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
WTZ-GIST-09-01 (Imatinib + LBH589) Patient registration2009-011417-24 DRKS00000657
WTZ-GIST-09-01 (Imatinib + LBH589) Patient registration 2009-011417-24
Description
Study Centrer Information - ATTENTION! This part will be completed by the center in Essen
Alias
- UMLS CUI-1
- C2825181
- UMLS CUI-2
- C1533716
Description
Clinical Trial Subject Unique Identifier
Data type
integer
Alias
- UMLS CUI [1]
- C2348585
Description
Cohort
Data type
integer
Alias
- UMLS CUI [1]
- C0599755
Description
Date of report - study center
Data type
date
Measurement units
- YYYY-MM-DD
Alias
- UMLS CUI [1]
- C1302584
- UMLS CUI [2]
- C2825181
Description
Signature patient registration center
Data type
boolean
Alias
- UMLS CUI [1]
- C2346576
- UMLS CUI [2]
- C2825181
Similar models
WTZ-GIST-09-01 (Imatinib + LBH589) Patient registration 2009-011417-24
C1533716 (UMLS CUI-2)
C2825181 (UMLS CUI [2])
C2825181 (UMLS CUI [2])